| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
New paper describes the first superabsorbent hydrogel technology made from naturally derived building blocks designed to address obesity and gut related conditions by emulating compositional and mechanical properties of raw vegetables
The newly published data showed that specific mechanical properties (elastic component/firmness) of Gelesis hydrogels were beneficial in protecting gut tissue from toxin damage in an ex-vivo model
First product based on this platform, Plenity®, is now FDA cleared and available by prescription to aid in weight management
Gelesis’ pipeline includes several other therapeutic product candidates in advanced clinical development to potentially treat a range of indications including diet-induced gut damage
Posted In: CPSR
